Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?
about
Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission TomographyMulticenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With LymphomaHodgkin disease-an ever-evolving therapy.Contribution of the 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography to the diagnosis of primary osseous Hodgkin lymphomaExtranodal lymphoma originating in the gluteal muscle with adjacent bone involvement and mimicking a soft tissue sarcoma.Appropriateness criteria of FDG PET/CT in oncology.18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell LymphomaPET and PET/CT for response evaluation in lymphoma: current practice and developments.State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.(18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinomaCombined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma.Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase.Current status of PET/CT in the diagnosis and follow up of lymphomas.When should FDG-PET be used in the modern management of lymphoma?Current role of FDG PET/CT in lymphoma.Integrated FDG PET/CT: Utility and Applications in Clinical Oncology.PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.Role of multimodality imaging in the diagnosis of lymphoproliferative malignancies and hematologic disorders of the kidneys.T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes.Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma.The role of FDG-PET in Hodgkin lymphomaFluoro-deoxy-glucose positron emission tomography/computed tomography in lymphoma: A pictorial essay.Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study.Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.[Extranodal abdominal lymphomas].Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan.Unusual discrepancy between CT and PET/CT in the initial staging of Hodgkin's lymphoma.Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans.F-18 FDG PET-CT Versus Contrast Enhanced CT in Detection of Extra Nodal Involvement in Patients with Lymphoma.Diagnostic value of software-based image fusion of computed tomography and F18-FDG PET scans in patients with malignant lymphoma
P2860
Q26801870-3BA45741-3819-4C72-B52E-BF2368FF0BA5Q30491972-7F808538-EB6A-42B9-8C64-C848FA87A7D8Q34463426-C345D498-5208-400D-A808-9583E35CE6C4Q34533431-D99DDED2-2A71-4393-94B2-961782056F71Q35107483-7E42B562-A213-4D36-B55D-7FAC69EE9305Q35568776-426861D0-AEF9-4ED3-94DC-250DB53220D8Q35855599-AA764EBD-941E-44F2-BBD2-A5442F31A8F6Q36746441-01DA9D62-36D5-482A-8D68-94DD2D93DCC7Q37144956-26D3F1D6-8441-4665-B00B-0239098A1DF5Q37240835-975CEABF-A910-4107-9EB5-E569447068F6Q37242788-70B2BE9C-BEAF-4A3F-8998-8BE3F96E42C7Q37326204-F6A8BE6E-1930-47FB-AE77-047065EEC97AQ37602246-7B5D3346-98AD-456F-A365-1C081AFA45E8Q38071295-AB82D774-4668-4803-BE14-2294D3F0C645Q38153086-F0F1317D-68F6-4001-B2DA-5153D0C32CF0Q38187365-A8188EC9-13E5-478F-B81F-A3DEE6D6C4AEQ38260852-1EC9298C-F9BB-4C6B-A364-AA0CED5589BCQ38794783-C71E6B23-B6D0-49ED-8F72-9EB46F445DC6Q38930330-803E1D0D-D067-4AEF-826B-5F7D042FF536Q39092818-47EB3223-2A61-48F0-837B-1D067563F7ADQ39456225-DC88E15C-0968-4E69-9855-4076390090D0Q41691698-6CA4B7C5-BC33-4F2F-AAC8-715C9CAD76D2Q42124199-2D23CCB7-B7BF-4E1A-8E09-691978EC2072Q43507515-A92E9C73-6CF7-442C-B8F8-AF93A9DBC396Q44624532-C3F9644C-6A88-40AF-B478-8678E37A5C05Q49987402-B82C3435-CA65-4930-8B5A-EB64A02DC5B4Q51931374-86FA1B8D-5C83-4C8B-A36F-47D42AD7EA53Q52990564-A3DC7D8C-4AD0-4763-AD3D-E5B36B129D08Q53277951-2E523D0E-31AC-4B32-BCBB-70A20EC79997Q53474462-FA1BC4CD-5BC4-4436-870E-7C4ADE5E87E1Q55379821-0DA45403-593F-4D4F-B9F9-DD30278F4ECCQ57649798-EB4705D2-8AD1-400D-A236-8C3CE2E89B23
P2860
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Is CT scan still necessary for ...... ma patients in the PET/CT era?
@en
Is CT scan still necessary for ...... ma patients in the PET/CT era?
@nl
type
label
Is CT scan still necessary for ...... ma patients in the PET/CT era?
@en
Is CT scan still necessary for ...... ma patients in the PET/CT era?
@nl
prefLabel
Is CT scan still necessary for ...... ma patients in the PET/CT era?
@en
Is CT scan still necessary for ...... ma patients in the PET/CT era?
@nl
P2093
P2860
P356
P1433
P1476
Is CT scan still necessary for ...... ma patients in the PET/CT era?
@en
P2093
A Polliack
E Even-Sapir
E Naparstek
I Ben-Bassat
P2860
P304
P356
10.1093/ANNONC/MDJ024
P577
2005-09-28T00:00:00Z